Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in ... - Nature

Retrieved on: 2024-09-15 23:30:31

Tags for this article:

Click the tags to see associated articles and topics

Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in ... - Nature. View article details on hiswai:

Excerpt

Further exploratory analysis using gene expression profiles (Fig. 5e) of SCLC patients indicated that KMT2D mutations affect various immune cell ...

Article found on: www.nature.com